About Viramal

Viramal has a rich portfolio offering a range of therapies in varying stages of development from pre-clinical to pivotal phase III studies. Of these products, Viramal’s only male product, TestoCream ™, Testosterone Replacement Therapy is in Phase III clinical development and available for out-licensing, as are Viramal’s two OTC products for female sexual health, which include Elegant ™ Vaginal Moisturizer.

Viramal offers both prescription and non-prescription drugs developed under its platform technologies for delivery both trans-dermally and vaginally.


Focus on reducing side effects, through bypassing the first hepatic or liver pass effect


Highly tolerable “cosmetic” grade products offering better patient acceptability for chronic use


Localised as well as systemic targeted delivery to optimise drug concentration where required and reduce overall drug exposure and adverse effects.